Title : Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes.

Pub. Date : 2004 Dec

PMID : 15562200






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes. Metformin dipeptidyl peptidase 4 Homo sapiens
2 OBJECTIVE: To assess the 12- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 versus placebo in patients with type 2 diabetes continuing metformin treatment. Metformin dipeptidyl peptidase 4 Homo sapiens